We noted that among these genes, UBE2C (Ubiquitin-conjugating enzyme E2 C) showed the highest fold change in expression between the cholangiocarcinoma tumor tissue and non-cancerous livers (log2 ratio = 1.7925; p-value < 0.0001) (Table 1). The gene discussed is UBE2C; the disease is cholangiocarcinoma.